Physician profile
Blake A Johnson
NPI 1811964174
$21,112.96
in general payments reported to CMS, 2019-2025
7 companies · $3,356 in 2025
The $3,356 reported for 2025 was more than what 93% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,199 · 2020: $2,103 · 2021: $4,240 · 2022: $5,055 · 2023: $4,139 · 2024: $20.73 · 2025: $3,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Travel and Lodging: $2,198 · Honoraria: $1,500 · Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Travel and Lodging | $2,198.03 |
| Honoraria | $1,500.00 |
| Food and Beverage | $1,067.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $9,829.62 | 2020-2023 | |
| Guerbet LLC | $7,289.42 | 2023-2025 | Elucirem, Elucirem |
| Medtronic USA, INC. | $2,525.00 | 2019-2020 | |
| Hitachi Healthcare Americas Corp. | $954.57 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $392.46 | 2021-2024 | Magnetom Vida, Magnetom Aera |
| Aidoc Medical LTD | $106.00 | 2019 | |
| Urovant Sciences INC | $15.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.